Bunge Global (BG) Lags Q4 Earnings Estimates
Bunge Global (BG) came out with quarterly earnings of $2.13 per share, missing the Zacks Consensus Estimate of $2.30 per share. This compares to earnings of $3.70 per share a year ago.
Bunge Gears Up to Report Q4 Earnings: Here's What to Expect
BG's Q4 results are anticipated to reflect weak year-over-year performances in its segments and the impacts of the divestiture of the Sugar and Bioenergy segment.
Analysts Estimate Bunge Global (BG) to Report a Decline in Earnings: What to Look Out for
Bunge Global (BG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bunge & Viterra Merger Cleared by Canada Government, Set to Close Soon
The government of Canada gives the green light to the BG -Viterra merger, subject to certain conditions.
Canada approves $34 billion Bunge-Viterra merger with conditions
The Canadian government said on Tuesday it approved with conditions the $34 billion merger deal between Bunge and the Glencore-backed company Viterra.
Bunge: Too Low Valuation, I'm Going In
Bunge S.A., a leader in oilseed processing, faces operational challenges but offers long-term upside, making it an attractive investment at current valuations. Despite a volatile earnings environment, Bunge's BBB+ rating, 3.5% yield, and strategic moves, including the Viterra merger, enhance its investment appeal. The company's valuation is compelling, trading below sector averages, with a potential upside of over 30% and a price target of $125/share by 2026.
Archer-Daniels-Midland: Valuation Is Low, But Bunge May Be A Better Deal
Archer-Daniels-Midland's valuation is low, with a forward P/E of 11.7X and a 3.7% dividend yield, but faces weak YoY performance and accounting investigations. Rising labor and energy costs, regulatory scrutiny, and shifting consumer trends weigh on ADM's profitability and long-term prospects. ADM's nutrition segment is under investigation, leading to restated financials, a significant decline in operating profit earlier this year, and delayed Q3 results.
Bunge Global (BG) Q3 2024 Earnings Call Transcript
Bunge Global SA (NYSE:BG ) Q3 2024 Earnings Conference Call October 30, 2024 8:00 AM ET Company Participants Greg Heckman - Chief Executive Officer John Neppl - Chief Financial Officer Ruth Ann Wisener - Vice President, Investor Relations Conference Call Participants Andrew Strelzik - BMO Capital Markets Salvatore Tiano - Bank of America Tom Palmer - Citi Manav Gupta - UBS Heather Jones - Heather Jones Research Stephen Hayes - Morgan Stanley Ben Theurer - Barclays Operator Good day and welcome to the Bunge Global SA third quarter 2024 earnings release and conference call. All participants will be in listen-only mode.
Here's What Key Metrics Tell Us About Bunge Global (BG) Q3 Earnings
While the top- and bottom-line numbers for Bunge Global (BG) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Bunge Global (BG) Tops Q3 Earnings and Revenue Estimates
Bunge Global (BG) came out with quarterly earnings of $2.29 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $2.99 per share a year ago.
Bunge Global (BG) Expected to Beat Earnings Estimates: Should You Buy?
Bunge Global (BG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bunge Global: Awaiting Q3 Earnings As The Shares Move Lower
I recommend a scale-down buying approach for Bunge Global SA shares, especially during price weakness, due to its strong fundamentals and attractive dividend yield. BG shares have declined 14.8% since mid-May 2024, nearing the bottom of their $80-$120 range, with earnings expected at the end of October. Lower grain, oilseed, and ethanol prices have pressured BG's earnings, but higher sugar and soybean crush spreads offer some relief.
